Skip to main content

Table 2 Endometriosis-associated pain symptoms intergroup comparison at baseline and at 3, 6 and 12 months of women on 24/4 regimen 17β-estradiol (1.5 mg) and Nomegestrol Acetate (2.5 mg) (E2/NOMAC) combined oral contraceptive, or on Dienogest (DNG) 2 mg daily

From: Randomized study on the effectiveness of nomegestrol acetate plus 17β-estradiol oral contraceptive versus dienogest oral pill in women with suspected endometriosis‑associated chronic pelvic pain

Pain symptoms

Baseline

3rd month

6th month

12th month

95% CI

P*

95% CI

P*

95% CI

P*

95% CI

P*

Chronic Pelvic Pain

− 0.06 to 1.06

0.08

− 0.82 to 0.02

0.06

0.13 to 1.26

0.01

− 0.02 to 0.82

0.06

Dysmenorrhea

− 4.61 to 1.01

0.2

− 0.48 to 2.88

0.1

0.32 to 4.47

0.02

− 0.6 to 2.8

0.2

Dyspareunia

− 4.51 to 1.11

0.12

− 1.35 to 5.95

0.2

1.12 to 5.27

0.003

− 0.96 to 2.96

0.2

  1. *t = two-sided t test; CI = Confidence interval